Generic drugs are the rare part of American health care that actually drives down costs. In 2024, they accounted for 90 ...
Generics a Commonsense Answer to High Drug Prices ...
A new study has found that generic drugs manufactured in India are linked to significantly more severe adverse events — including hospitalization, disability and in some cases death — compared to ...
Generic medications are not the same as brand medications. Small differences in ingredients that are permitted by the FDA may ...
The United States is amid a dangerous drug shortage that endangers patients, undermines our health care system and exposes a deep vulnerability to national security. America’s overwhelming reliance on ...
MedPage Today on MSN
US has no backup plan if foreign generic drugmakers bow out, senator says
"If we can't solve this problem, it's only a matter of time" before lives are lost ...
Delve into the Amarin v. Hikma case in which the U.S. Supreme Court might settle the skinny label question once and for all.
The Supreme Court on Jan. 16, 2026, agreed to decide a case about how generic companies can communicate to the market about their products, ...
On January 16, 2026, the U.S. Supreme Court agreed to hear Hikma Pharmaceuticals USA, Inc. v. Amarin Pharma, Inc., a patent ...
In 2018, Health Canada authorized semaglutide injections — more famously known by the brand name Ozempic — for blood sugar ...
FDA approves first generic florfenicol–flunixin injectable (nixiFLOR) for bovine respiratory disease
The FDA has approved nixiFLOR, the first generic florfenicol-flunixin injectable, for treatment of bovine respiratory disease and control of associated fever in beef and nonlactating dairy cattle.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results